24 March 2017Americas

Pfizer sues Breckenridge over rheumatoid arthritis drug

Pfizer has sued Breckenridge Pharmaceutical, Pensa Pharma and Laboratorios del Dr Esteve for patent infringement of its drug Xeljanz (tofacitinib).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
10 August 2018   Novartis and Breckenridge settled their differences over a generic version of Novartis’s cancer drug Afinitor earlier this week.

More on this story

Americas
10 August 2018   Novartis and Breckenridge settled their differences over a generic version of Novartis’s cancer drug Afinitor earlier this week.

More on this story

Americas
10 August 2018   Novartis and Breckenridge settled their differences over a generic version of Novartis’s cancer drug Afinitor earlier this week.